BMT Shares Beamtree Holdings Limited
ASX · ASXLast in our picks 2026-09-30 — not in the current list; analysis below is from that screen
Healthcare AI decision-support has recurring revenue potential and near-term adoption catalysts.
Future value: $0.25 (+150.00%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Positive healthcare AI momentum and contract-led growth underpin buying interest.
- ▾Below 50-day MA (-13.74%)
- ▾Near 52-week low (12.5% of range)
- ▸~150% upside to price target
Is BMT a buy right now?
Trend: BMT is trading below the 50-day average (-23.00%), RSI 41 — neutral momentum, with a 3-month return of -40.77%.
Valuation & quality: Beamtree Holdings Limited trades on forward P/E 77.0, price-to-book 0.96; fundamentals show net margin -62.6%, return on equity -56.0%, revenue growth 2.1% year on year.
Analyst consensus: 1 analysts have a mean 12-month price target of A$0.25 (+224.7% vs the last close; range A$0.25 – A$0.25), consensus rating “none”.
Our screen: BUY (score 3) — Healthcare AI decision-support has recurring revenue potential and near-term adoption catalysts.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -6.20% | -20.00% | -16.70% | +40.00% | +0.00% | -21.40% | -9.10% | -20.00% |
Fundamentals
Analyst price target
Technical signals
About Beamtree Holdings Limited
Beamtree Holdings Limited provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally.
Sector: Healthcare · Industry: Health Information Services · Australia · 93 employees · Website
Related Artificial Intelligence picks
Browse: all ASX stocks · Artificial Intelligence picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.